Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) P/B ratio
As of 5 November 2026, Chemed Corporation (CHE) trades at a P/B ratio of 8.1×. Over the past ten years it has ranged from 3.8× (January 2015) to 13.3× (December 2021); the current reading is higher than 51% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 6.3× | (11.58%) |
| FY2024 | 7.1× | (10.42%) |
| FY2023 | 7.9× | (16.19%) |
| FY2022 | 9.5× | (28.77%) |
| FY2021 | 13.3× | 41.07% |
| FY2020 | 9.4× | (2.32%) |
| FY2019 | 9.7× | 25.49% |
| FY2018 | 7.7× | 4.82% |
| FY2017 | 7.3× | 44.83% |
| FY2016 | 5.1× | 2.92% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 7.7× | 3.63% |
| Jun 2026 | 7.4× | 21.28% |
| Mar 2026 | 6.1× | (3.15%) |
| Dec 2025 | 6.3× | 5.08% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| DVA DaVita Inc. compare | n/m |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| LFST LifeStance Health Group, Inc. compare | 3.4× |
| OPCH Option Care Health, Inc. compare | 3.7× |
| ENSG The Ensign Group, Inc. compare | 4.1× |
| PACS PACS Group, Inc. compare | 6.5× |
| CHE Chemed Corporation | 8.1× |
| CON Concentra Group Holdings Parent, Inc. compare | 10.2× |
| UHS Universal Health Services, Inc. compare | 164× |
| Medical Care Facilities industry median | 3.1× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement